NCT00389428View on ClinicalTrials.gov

Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2009

Conditions
Hematologic Neoplasms
Interventions
DRUG

CPX-351 (Cytarabine:Daunorubicin) Liposome Injection

Trial Locations (4)

10021

New York Presbyterian Hospital Weill Medical College of Cornell University, New York

11030

North Shore University Hospital, Manhasset

20007

Georgetown University Medical Center, Washington D.C.

33612-9497

H. Lee Moffit Cancer Center & Research Institute at the University of S. Florida, Tampa

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY